Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNext Regulatory News (NXT)

Share Price Information for Next (NXT)

Share Price is delayed by 15 minutes
Get Live Data
13,625.00    0.00 (0.00%)
Bid:
9,200.00
Ask:
0.00
Spread: 4,390.00 (47.717%)
Market Cap: £15.55b
NXT Live PriceLast checked at - London Stock Exchange

Intraday Next Share Chart

Update on Outstanding Notes and RCF

18 Jul 2025 14:17

RNS Number : 7203R
Next PLC
18 July 2025
 

18 July 2025

 

NEXT plc

 

Update on Outstanding Notes and RCF

 

 

NEXT plc announces that:

 

on 17 July 2025, NEXT Group plc (the "Issuer") issued £300,000,000 5.000 per cent. Notes due 2031 (ISIN: XS3116723712) (the "2031 Notes") unconditionally and irrevocably guaranteed by NEXT plc (the "Guarantor") under the Issuer's £3,000,000,000 Euro Medium Term Note Programme;

 

on 17 July 2025, the Issuer used part of the issuance proceeds of the 2031 Notes to purchase an aggregate nominal amount of £136,430,000 of its £250,000,000 4.375 per cent. Bonds due 2026 guaranteed by the Guarantor (ISIN: XS0975833319);

 

as at 18 July 2025, the outstanding nominal amount of all notes issued by the Issuer and guaranteed by the Guarantor is:

 

o £250,000,000 3.000 per cent. Bonds due 2025 (ISIN: XS1985037974), maturing on 26 August 2025;

 

o £113,570,000 4.375 per cent. Bonds due 2026 (ISIN: XS0975833319), maturing on 2 October 2026;

 

o £300,000,000 3.625 per cent. Bonds due 2028 (ISIN: XS1410414954), maturing on 18 May 2028; and

 

o £300,000,000 5.000 per cent. Notes due 2031 (ISIN: XS3116723712), maturing on 17 July 2031; and

 

on 11 April 2025, NEXT Group plc increased the available commitments under its revolving credit facility (the "RCF") by £100,000,000 to an aggregate amount of £525,000,000, which, as at the date of this announcement, remains undrawn, bringing the total amount of available commitments under the RCF and the outstanding notes to £1,488.57m.

 

 

Important Information

 

This Announcement does not constitute, or form part of, any offer or any solicitation of an offer to acquire or subscribe for any shares, bonds or any other securities, nor shall it (or any part of it) or the fact of its dissemination form the basis of, or be relied on in connection with, any contract with respect thereto.

 

THIS ANNOUNCEMENT IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN THE UNITED STATES OF AMERICA, ITS TERRITORIES AND POSSESSIONS (INCLUDING PUERTO RICO, THE U.S. VIRGIN ISLANDS, GUAM, AMERICAN SAMOA, WAKE ISLAND AND THE NORTHERN MARIANA ISLANDS), ANY STATE OF THE UNITED STATES OF AMERICA OR THE DISTRICT OF COLUMBIA (THE UNITED STATES) OR IN OR INTO OR TO ANY PERSON LOCATED OR RESIDENT IN ANY OTHER JURISDICTION WHERE OR TO WHOM IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFLFLVDIITLIE
Date   Source Headline
20th Mar 20235:16 pmRNSTransaction in Own Shares
17th Mar 20235:08 pmRNSTransaction in Own Shares
16th Mar 20235:21 pmRNSTransaction in Own Shares
15th Mar 20235:01 pmRNSTransaction in Own Shares
14th Mar 20235:30 pmRNSTransaction in Own Shares
13th Mar 20235:11 pmRNSTransaction in Own Shares
10th Mar 20235:48 pmRNSTransaction in Own Shares
9th Mar 20235:21 pmRNSTransaction in Own Shares
8th Mar 20235:15 pmRNSTransaction in Own Shares
7th Mar 20235:34 pmRNSTransaction in Own Shares
6th Mar 20235:28 pmRNSTransaction in Own Shares
3rd Mar 20235:06 pmRNSTransaction in Own Shares
2nd Mar 20235:23 pmRNSTransaction in Own Shares
1st Mar 20234:43 pmRNSTransaction in Own Shares
1st Mar 20239:00 amRNSTotal Voting Rights
28th Feb 20235:29 pmRNSTransaction in Own Shares
27th Feb 20235:23 pmRNSTransaction in Own Shares
24th Feb 20235:18 pmRNSTransaction in Own Shares
24th Feb 202311:52 amRNSClosed Period Share Repurchase Programme
23rd Feb 20234:53 pmRNSTransaction in Own Shares
22nd Feb 20235:44 pmRNSTransaction in Own Shares
21st Feb 20235:03 pmRNSTransaction in Own Shares
20th Feb 20235:35 pmRNSTransaction in Own Shares
17th Feb 20235:15 pmRNSTransaction in Own Shares
16th Feb 20235:21 pmRNSTransaction in Own Shares
15th Feb 20235:14 pmRNSTransaction in Own Shares
15th Feb 20234:14 pmRNSHolding(s) in Company
14th Feb 20235:20 pmRNSTransaction in Own Shares
13th Feb 20235:23 pmRNSTransaction in Own Shares
10th Feb 20235:27 pmRNSTransaction in Own Shares
9th Feb 20235:11 pmRNSTransaction in Own Shares
8th Feb 20235:26 pmRNSTransaction in Own Shares
8th Feb 202311:00 amRNSNew Executive Director Appointment
7th Feb 20235:53 pmRNSTransaction in Own Shares
7th Feb 202312:27 pmRNSHolding(s) in Company
1st Feb 20238:26 amRNSTotal Voting Rights
5th Jan 20237:00 amRNSTrading Statement
3rd Jan 20239:30 amRNSTotal Voting Rights
1st Dec 20221:32 pmRNSAcquisition
1st Dec 20221:30 pmRNSAcquisition of Joules by NEXT Plc and Tom Joule
1st Dec 20229:00 amRNSTotal Voting Rights
9th Nov 20229:13 amRNSAcquisition
2nd Nov 20227:00 amRNSTrading Statement
1st Nov 20228:53 amRNSTotal Voting Rights
21st Oct 20223:17 pmRNSHolding(s) in Company
21st Oct 202212:01 pmRNSHolding(s) in Company
13th Oct 202212:20 pmRNSHolding(s) in Company
10th Oct 20222:12 pmRNSHolding(s) in Company
4th Oct 20221:01 pmRNSDirector/PDMR Shareholding
3rd Oct 20225:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.